PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine to teams, organizations, and athletes. The company provides treatment for concussive and sub-concussive brain injury through the portable cooling device PolarCap System.

The FIFA World Cup Qatar 2022 is expected to be one of the most viewed sporting events on the globe ever, and the deal provides a big opportunity for PolarCap to receive potential exposure in both the sports medicine and public domains.

Erik Andersson's (PolarCool CEO) comments:

-The Welsh Football Association's medical department sees the benefits of providing the product to its men's team during the World Cup. It is a great recognition for us and shows the importance of having PolarCap Systems in place to alleviate the effect of brain injuries in football.

Following the Men's National teams use of PolarCap during their World cup campaign, the FAW Women's team and Junior teams will have access to the device throughout the one-year agreement. The agreements are limited in size but are an important strategic step for PolarCool into the international football market.

Whilst the average concussion rates are lower in football compared to sports like rugby or ice hockey, football remains a target sport for PolarCool due to the sports increasing concern surrounding the injury. FIFA has spent considerable focus to raise awareness and improve the direct management of concussion in recent years and is one of the top organizations to attend the upcoming 6[th] International Consensus Conference on concussion in Sports, taking place in Amsterdam from the 27-28 of October.